Featured Article

The research in animal models suggests that these new therapies could not only treat Alzheimer’s, but also other neurodegenerative diseases characterized by protein aggregation, such as motor neurone disease, Huntington’s disease, and Parkinson’s disease.

Precision Oncology Today

Magazine

Applying Precision Technology to Tackle Climate-Driven Infectious Diseases

The devastating impact that infectious diseases can have on the global population was well demonstrated by the COVID-19 pandemic. Fortunately, pandemics remain unusual occurrences, but research suggests that factors such as climate change may be increasing the risk of such events occurring in the future. Integrative projects that simultaneously tackle infectious disease risks, climate change, and other environmental issues could help solve a complicated global problem.
Blood Testing

Minimal Disease, Maximum Benefit

As both flow cytometry technology and genomic sequencing have taken technological leaps forward, the sensitivity and specificity of testing has increased to include MRD for solid tumors. Leveraging advances in next-generation sequencing, MRD test developers can look for thousands of disease markers and even detect one cancerous cell among a million healthy cells. This level of sensitivity provides evidence of disease recurrence months before traditional follow-up screening methods.
Antibodies Background

Immunogenomics is on the Way Up

Combining immune-system science, omics, and various computational algorithms might produce success where advanced cancer treatments have failed.

Trending on Inside Precision Medicine

Weight loss pills and unhealthy dieting with medication concept

Study Identifies Key Factors for Long-Term Weight Loss with GLP-1 Medications

A recent Cleveland Clinic study has shed light on the critical factors influencing long-term weight loss in patients with obesity prescribed GLP-1 receptor agonist (RA) medications like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda, Victoza).
doctor hold coronavirus vaccine in hospital laboratory

AI Effectively Allocates Resources in Pandemic

Research suggests that machine learning could have helped reduce hospitalizations by more than a quarter during the COVID-19 pandemic by determining how to best allocate limited resources, in the form of personalized public health decision making.
Image showing pathological phosphorylation (yellow) of Tau proteins (red-orange) leads to disintegration of microtubuli in the neuron axon an aggregation of the tau proteins. The transport of synaptic vesicles (orange-blue) is interrupted. This is just part of the disease pathology seen in a single cell map of the Alzheimer's disease brain.

New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease

The research in animal models suggests that these new therapies could not only treat Alzheimer’s, but also other neurodegenerative diseases characterized by protein aggregation, such as motor neurone disease, Huntington’s disease, and Parkinson’s disease.

Daily News

Related Content

Inside Precision Medicine